DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 040534
NDA 040534 describes BETHANECHOL CHLORIDE, which is a drug marketed by Able, Actavis Elizabeth, Amneal Pharm, Ascot, Eci Pharms Llc, Heritage Pharma, Impax Labs, Ivax Sub Teva Pharms, Lannett, Lannett Holdings Inc, Sandoz, Sun Pharm Inds Inc, Upsher-smith Labs, Watson Labs, and Wockhardt, and is included in forty-seven NDAs. It is available from seventeen suppliers. Additional details are available on the BETHANECHOL CHLORIDE profile page.
The generic ingredient in BETHANECHOL CHLORIDE is bethanechol chloride. There are eight drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the bethanechol chloride profile page.
The generic ingredient in BETHANECHOL CHLORIDE is bethanechol chloride. There are eight drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the bethanechol chloride profile page.
Summary for 040534
| Tradename: | BETHANECHOL CHLORIDE |
| Applicant: | Wockhardt |
| Ingredient: | bethanechol chloride |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Pharmacology for NDA: 040534
| Mechanism of Action | Cholinergic Muscarinic Agonists |
Medical Subject Heading (MeSH) Categories for 040534
Suppliers and Packaging for NDA: 040534
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| BETHANECHOL CHLORIDE | bethanechol chloride | TABLET;ORAL | 040534 | ANDA | Wockhardt Limited | 55648-967 | E | 55648-967-01 |
| BETHANECHOL CHLORIDE | bethanechol chloride | TABLET;ORAL | 040534 | ANDA | Wockhardt USA LLC. | 64679-967 | N | 64679-967-01 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
| Approval Date: | Sep 29, 2003 | TE: | AA | RLD: | No | ||||
Complete Access Available with Subscription
